| 0 |
APPLICATION SITE STREAKING |
1 |
0.0769 |
| 1 |
NOCTURNAL HYPERTENSION |
1 |
0.0455 |
| 2 |
PROSTATIC CYST |
1 |
0.0345 |
| 3 |
ADMINISTRATION SITE CELLULITIS |
1 |
0.0286 |
| 4 |
TENDON TRANSFER |
1 |
0.0238 |
| 5 |
AMPUTEE |
1 |
0.0152 |
| 6 |
ADMINISTRATION SITE WARMTH |
1 |
0.0122 |
| 7 |
VASCULAR ACCESS SITE EXTRAVASATION |
1 |
0.0115 |
| 8 |
VANCOMYCIN INFUSION REACTION |
4 |
0.0106 |
| 9 |
INFUSION SITE HYPOAESTHESIA |
1 |
0.0105 |
| 10 |
VASCULAR SKIN DISORDER |
1 |
0.0101 |
| 11 |
COAGULATION TIME ABNORMAL |
3 |
0.0100 |
| 12 |
INFUSION SITE PARAESTHESIA |
1 |
0.0099 |
| 13 |
CYSTIC FIBROSIS LUNG |
1 |
0.0078 |
| 14 |
INFUSION SITE THROMBOSIS |
2 |
0.0075 |
| 15 |
APPLICATION SITE NODULE |
1 |
0.0073 |
| 16 |
THERAPEUTIC PRODUCT CROSS-REACTIVITY |
6 |
0.0067 |
| 17 |
PARASPINAL ABSCESS |
1 |
0.0065 |
| 18 |
CARCINOMA IN SITU |
1 |
0.0060 |
| 19 |
IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY |
1 |
0.0057 |
| 20 |
JEJUNOSTOMY |
1 |
0.0055 |
| 21 |
BREATH HOLDING |
2 |
0.0052 |
| 22 |
GREATER TROCHANTERIC PAIN SYNDROME |
1 |
0.0049 |
| 23 |
POST PROCEDURAL FEVER |
1 |
0.0041 |
| 24 |
INCISION SITE ABSCESS |
1 |
0.0038 |
| 25 |
EYE HAEMATOMA |
1 |
0.0038 |
| 26 |
PALPABLE PURPURA |
1 |
0.0036 |
| 27 |
RELAPSING FEVER |
1 |
0.0035 |
| 28 |
RED MAN SYNDROME |
3 |
0.0034 |
| 29 |
VULVOVAGINITIS |
1 |
0.0034 |
| 30 |
INFUSION SITE EXTRAVASATION |
21 |
0.0034 |
| 31 |
HYPOPROTHROMBINAEMIA |
1 |
0.0033 |
| 32 |
INFUSION SITE NODULE |
3 |
0.0031 |
| 33 |
ADMINISTRATION SITE SWELLING |
1 |
0.0031 |
| 34 |
VULVITIS |
1 |
0.0030 |
| 35 |
CATHETER SITE IRRITATION |
1 |
0.0030 |
| 36 |
GRANULOMA ANNULARE |
2 |
0.0027 |
| 37 |
HUMAN RHINOVIRUS TEST POSITIVE |
1 |
0.0027 |
| 38 |
SENSATION OF BLOOD FLOW |
1 |
0.0026 |
| 39 |
UREAPLASMA INFECTION |
1 |
0.0025 |
| 40 |
NEUTRALISING ANTIBODIES POSITIVE |
1 |
0.0024 |
| 41 |
GASTROINTESTINAL HYPERMOTILITY |
1 |
0.0023 |
| 42 |
CERVICITIS |
1 |
0.0022 |
| 43 |
PRODUCT RECONSTITUTION QUALITY ISSUE |
2 |
0.0022 |
| 44 |
GASTROINTESTINAL STOMA OUTPUT INCREASED |
1 |
0.0021 |
| 45 |
INFUSION SITE HAEMATOMA |
1 |
0.0021 |
| 46 |
CROSS SENSITIVITY REACTION |
2 |
0.0021 |
| 47 |
ADMINISTRATION SITE EXTRAVASATION |
2 |
0.0020 |
| 48 |
SEPSIS SYNDROME |
1 |
0.0020 |
| 49 |
SUSPECTED PRODUCT CONTAMINATION |
2 |
0.0020 |
| 50 |
MALE ORGASMIC DISORDER |
1 |
0.0019 |
| 51 |
CORYNEBACTERIUM INFECTION |
1 |
0.0019 |
| 52 |
OSTEOMYELITIS ACUTE |
1 |
0.0018 |
| 53 |
TYPE III IMMUNE COMPLEX MEDIATED REACTION |
1 |
0.0018 |
| 54 |
ORTHOSTATIC HYPERTENSION |
1 |
0.0017 |
| 55 |
SERUM SICKNESS-LIKE REACTION |
1 |
0.0016 |
| 56 |
CHONDROCALCINOSIS |
1 |
0.0015 |
| 57 |
INFUSION SITE URTICARIA |
1 |
0.0015 |
| 58 |
INFUSION SITE RASH |
2 |
0.0015 |
| 59 |
BLISTER RUPTURE |
1 |
0.0013 |
| 60 |
EOSINOPHIL COUNT ABNORMAL |
1 |
0.0013 |
| 61 |
AMPHETAMINES POSITIVE |
1 |
0.0013 |
| 62 |
MULTIPLE-DRUG RESISTANCE |
4 |
0.0013 |
| 63 |
BLISTER INFECTED |
1 |
0.0013 |
| 64 |
DEAFNESS NEUROSENSORY |
4 |
0.0012 |
| 65 |
GLOMERULAR FILTRATION RATE INCREASED |
1 |
0.0012 |
| 66 |
INFUSION SITE OEDEMA |
1 |
0.0012 |
| 67 |
SUPERFICIAL VEIN THROMBOSIS |
1 |
0.0012 |
| 68 |
PERIORBITAL PAIN |
1 |
0.0012 |
| 69 |
PRODUCT PREPARATION ERROR |
24 |
0.0012 |
| 70 |
ENTEROCUTANEOUS FISTULA |
1 |
0.0011 |
| 71 |
INCORRECT PRODUCT FORMULATION ADMINISTERED |
1 |
0.0011 |
| 72 |
OTOTOXICITY |
2 |
0.0011 |
| 73 |
TONGUE INJURY |
1 |
0.0011 |
| 74 |
RED BLOOD CELL ABNORMALITY |
1 |
0.0010 |
| 75 |
DISCOLOURED VOMIT |
1 |
0.0010 |
| 76 |
VOMITING PROJECTILE |
3 |
0.0010 |
| 77 |
RED BLOOD CELLS URINE POSITIVE |
1 |
0.0010 |
| 78 |
INFUSION SITE REACTION |
3 |
0.0010 |
| 79 |
FOAMING AT MOUTH |
2 |
0.0010 |
| 80 |
PATHOGEN RESISTANCE |
9 |
0.0010 |
| 81 |
SKIN SENSITISATION |
1 |
0.0010 |
| 82 |
INFUSION SITE DISCOMFORT |
1 |
0.0010 |
| 83 |
INFUSION SITE SWELLING |
6 |
0.0010 |
| 84 |
BONE NEOPLASM |
1 |
0.0009 |
| 85 |
INFECTION REACTIVATION |
1 |
0.0009 |
| 86 |
ADMINISTRATION SITE PAIN |
1 |
0.0009 |
| 87 |
CHRONIC SPONTANEOUS URTICARIA |
1 |
0.0009 |
| 88 |
ARTHRITIS INFECTIVE |
4 |
0.0009 |
| 89 |
EAR PRURITUS |
3 |
0.0009 |
| 90 |
PROSTATIC OPERATION |
1 |
0.0008 |
| 91 |
INTRA-ABDOMINAL HAEMATOMA |
1 |
0.0008 |
| 92 |
ENDOCARDITIS |
4 |
0.0008 |
| 93 |
INFUSION SITE IRRITATION |
1 |
0.0008 |
| 94 |
PRODUCT PREPARATION ISSUE |
5 |
0.0008 |
| 95 |
FLANK PAIN |
7 |
0.0007 |
| 96 |
TYPE IV HYPERSENSITIVITY REACTION |
2 |
0.0007 |
| 97 |
EXTRAVASATION |
3 |
0.0007 |
| 98 |
DIABETIC FOOT INFECTION |
1 |
0.0007 |
| 99 |
VASCULAR INJURY |
1 |
0.0007 |
| 100 |
STAPHYLOCOCCAL BACTERAEMIA |
3 |
0.0007 |
| 101 |
FOOT AMPUTATION |
1 |
0.0007 |
| 102 |
NEPHRECTOMY |
1 |
0.0007 |
| 103 |
MIXED LIVER INJURY |
2 |
0.0007 |
| 104 |
URINE ABNORMALITY |
3 |
0.0007 |
| 105 |
BLOOD PRESSURE IMMEASURABLE |
1 |
0.0007 |
| 106 |
MYELITIS |
1 |
0.0006 |
| 107 |
LIMB DEFORMITY |
1 |
0.0006 |
| 108 |
TINEA PEDIS |
1 |
0.0006 |
| 109 |
INFUSION SITE PAIN |
8 |
0.0006 |
| 110 |
INFUSION SITE HAEMORRHAGE |
2 |
0.0006 |
| 111 |
SYSTEMIC INFECTION |
1 |
0.0006 |
| 112 |
GLOSSITIS |
2 |
0.0006 |
| 113 |
JUGULAR VEIN THROMBOSIS |
1 |
0.0006 |
| 114 |
INDURATION |
1 |
0.0006 |
| 115 |
PNEUMONIA KLEBSIELLA |
1 |
0.0005 |
| 116 |
INJECTION SITE CELLULITIS |
1 |
0.0005 |
| 117 |
MECHANICAL VENTILATION |
1 |
0.0005 |
| 118 |
HYPERVENTILATION |
3 |
0.0005 |
| 119 |
HYPERTRIGLYCERIDAEMIA |
3 |
0.0005 |
| 120 |
RENAL TUBULAR NECROSIS |
5 |
0.0005 |
| 121 |
JOINT NOISE |
1 |
0.0005 |
| 122 |
PNEUMONIA STAPHYLOCOCCAL |
1 |
0.0005 |
| 123 |
EMPYEMA |
1 |
0.0005 |
| 124 |
DEVICE RELATED SEPSIS |
1 |
0.0005 |
| 125 |
PERIPHERAL VENOUS DISEASE |
2 |
0.0005 |
| 126 |
ANAPHYLACTOID REACTION |
2 |
0.0005 |
| 127 |
INSULIN RESISTANCE |
1 |
0.0005 |
| 128 |
WALKING DISABILITY |
1 |
0.0005 |
| 129 |
INFUSION SITE ERYTHEMA |
4 |
0.0005 |
| 130 |
POOR QUALITY PRODUCT ADMINISTERED |
5 |
0.0005 |
| 131 |
EAR SWELLING |
1 |
0.0005 |
| 132 |
PURULENT DISCHARGE |
2 |
0.0005 |
| 133 |
NOSOCOMIAL INFECTION |
1 |
0.0005 |
| 134 |
INFUSION RELATED REACTION |
30 |
0.0005 |
| 135 |
ABDOMINAL ABSCESS |
2 |
0.0005 |
| 136 |
ANAPHYLACTIC REACTION |
25 |
0.0005 |
| 137 |
APPLICATION SITE URTICARIA |
1 |
0.0004 |
| 138 |
HAEMATOTOXICITY |
4 |
0.0004 |
| 139 |
VARICELLA |
1 |
0.0004 |
| 140 |
WEIGHT ABNORMAL |
1 |
0.0004 |
| 141 |
PULSE ABNORMAL |
1 |
0.0004 |
| 142 |
STARING |
1 |
0.0004 |
| 143 |
LIQUID PRODUCT PHYSICAL ISSUE |
3 |
0.0004 |
| 144 |
PHARYNGEAL SWELLING |
4 |
0.0004 |
| 145 |
INJECTION SITE EXTRAVASATION |
5 |
0.0004 |
| 146 |
DEVICE INFUSION ISSUE |
1 |
0.0004 |
| 147 |
GASTROINTESTINAL TUBE INSERTION |
1 |
0.0004 |
| 148 |
VEIN DISORDER |
2 |
0.0004 |
| 149 |
PLATELET DISORDER |
1 |
0.0004 |
| 150 |
PHLEBITIS |
2 |
0.0004 |
| 151 |
HEPATOSPLENOMEGALY |
1 |
0.0004 |
| 152 |
PRODUCT COLOUR ISSUE |
2 |
0.0004 |
| 153 |
MEAN CELL VOLUME INCREASED |
1 |
0.0004 |
| 154 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
4 |
0.0004 |
| 155 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
10 |
0.0004 |
| 156 |
CYANOSIS |
6 |
0.0004 |
| 157 |
BREAST SWELLING |
1 |
0.0004 |
| 158 |
SKIN WRINKLING |
1 |
0.0004 |
| 159 |
RASH MORBILLIFORM |
1 |
0.0004 |
| 160 |
STREPTOCOCCAL INFECTION |
2 |
0.0004 |
| 161 |
HEPATOTOXICITY |
8 |
0.0004 |
| 162 |
SERUM SICKNESS |
1 |
0.0004 |
| 163 |
LUNG CONSOLIDATION |
1 |
0.0004 |
| 164 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
2 |
0.0004 |
| 165 |
NEUTROPHIL COUNT ABNORMAL |
1 |
0.0004 |
| 166 |
FORCED EXPIRATORY VOLUME DECREASED |
1 |
0.0004 |
| 167 |
DRUG RESISTANCE |
9 |
0.0004 |
| 168 |
PHARYNGEAL DISORDER |
1 |
0.0003 |
| 169 |
FIBULA FRACTURE |
1 |
0.0003 |
| 170 |
FINE MOTOR SKILL DYSFUNCTION |
1 |
0.0003 |
| 171 |
ESCHERICHIA SEPSIS |
1 |
0.0003 |
| 172 |
BILIARY COLIC |
1 |
0.0003 |
| 173 |
STRIDOR |
1 |
0.0003 |
| 174 |
BACTERAEMIA |
4 |
0.0003 |
| 175 |
STAPHYLOCOCCAL INFECTION |
11 |
0.0003 |
| 176 |
METABOLIC ENCEPHALOPATHY |
1 |
0.0003 |
| 177 |
GANGRENE |
2 |
0.0003 |
| 178 |
PRURITUS GENERALISED |
7 |
0.0003 |
| 179 |
INFUSION SITE PRURITUS |
1 |
0.0003 |
| 180 |
THROAT IRRITATION |
14 |
0.0003 |
| 181 |
ACUTE RESPIRATORY FAILURE |
6 |
0.0003 |
| 182 |
BACTERIAL SEPSIS |
1 |
0.0003 |
| 183 |
INJECTION SITE INFECTION |
1 |
0.0003 |
| 184 |
TOXIC SKIN ERUPTION |
3 |
0.0003 |
| 185 |
WOUND DEHISCENCE |
1 |
0.0003 |
| 186 |
THROAT TIGHTNESS |
8 |
0.0003 |
| 187 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
5 |
0.0003 |
| 188 |
WOUND COMPLICATION |
1 |
0.0003 |
| 189 |
INTERNATIONAL NORMALISED RATIO ABNORMAL |
1 |
0.0003 |
| 190 |
CERVICAL VERTEBRAL FRACTURE |
1 |
0.0003 |
| 191 |
BLOOD CREATININE ABNORMAL |
1 |
0.0003 |
| 192 |
HYPERTRANSAMINASAEMIA |
2 |
0.0003 |
| 193 |
EOSINOPHILIA |
5 |
0.0003 |
| 194 |
MUSCLE CONTRACTIONS INVOLUNTARY |
1 |
0.0003 |
| 195 |
CLOSTRIDIUM DIFFICILE COLITIS |
3 |
0.0003 |
| 196 |
PRODUCT CONTAMINATION |
1 |
0.0003 |
| 197 |
OSTEOMYELITIS |
5 |
0.0003 |
| 198 |
SKIN LACERATION |
3 |
0.0003 |
| 199 |
SCLERODERMA |
1 |
0.0003 |
| 200 |
PRODUCT STORAGE ERROR |
24 |
0.0003 |
| 201 |
CUTANEOUS VASCULITIS |
1 |
0.0003 |
| 202 |
CHEST DISCOMFORT |
28 |
0.0003 |
| 203 |
LIP SWELLING |
9 |
0.0003 |
| 204 |
CHEMOTHERAPY |
1 |
0.0003 |
| 205 |
RASH MACULAR |
9 |
0.0003 |
| 206 |
PALLOR |
7 |
0.0003 |
| 207 |
WOUND SECRETION |
1 |
0.0003 |
| 208 |
BACK PAIN |
59 |
0.0003 |
| 209 |
RENAL CYST |
2 |
0.0003 |
| 210 |
EXPOSURE VIA BREAST MILK |
1 |
0.0003 |
| 211 |
HYPERPHAGIA |
1 |
0.0003 |
| 212 |
HYPERSENSITIVITY |
46 |
0.0002 |
| 213 |
POST PROCEDURAL INFECTION |
2 |
0.0002 |
| 214 |
TRIGGER FINGER |
1 |
0.0002 |
| 215 |
ARTHRITIS BACTERIAL |
1 |
0.0002 |
| 216 |
PULSELESS ELECTRICAL ACTIVITY |
1 |
0.0002 |
| 217 |
CELLULITIS |
12 |
0.0002 |
| 218 |
HYPERPYREXIA |
1 |
0.0002 |
| 219 |
ESCHERICHIA URINARY TRACT INFECTION |
1 |
0.0002 |
| 220 |
PRODUCT DISPENSING ISSUE |
1 |
0.0002 |
| 221 |
PSEUDOMONAS INFECTION |
2 |
0.0002 |
| 222 |
LIVER FUNCTION TEST INCREASED |
5 |
0.0002 |
| 223 |
URTICARIA |
39 |
0.0002 |
| 224 |
ANAPHYLACTIC SHOCK |
6 |
0.0002 |
| 225 |
DRUG ERUPTION |
4 |
0.0002 |
| 226 |
CATHETERISATION CARDIAC |
1 |
0.0002 |
| 227 |
WHEELCHAIR USER |
1 |
0.0002 |
| 228 |
ANAL INCONTINENCE |
2 |
0.0002 |
| 229 |
CHILLS |
26 |
0.0002 |
| 230 |
OROPHARYNGEAL DISCOMFORT |
2 |
0.0002 |
| 231 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 232 |
VASCULAR DEVICE INFECTION |
1 |
0.0002 |
| 233 |
RASH |
96 |
0.0002 |
| 234 |
BLOOD PRESSURE DIASTOLIC INCREASED |
1 |
0.0002 |
| 235 |
INTERCEPTED MEDICATION ERROR |
1 |
0.0002 |
| 236 |
FEELING COLD |
6 |
0.0002 |
| 237 |
VAGINAL INFECTION |
1 |
0.0002 |
| 238 |
SINUS TACHYCARDIA |
3 |
0.0002 |
| 239 |
BRONCHOSPASM |
3 |
0.0002 |
| 240 |
NON-SMALL CELL LUNG CANCER |
1 |
0.0002 |
| 241 |
RASH VESICULAR |
1 |
0.0002 |
| 242 |
FLUSHING |
21 |
0.0002 |
| 243 |
ERYTHEMA |
42 |
0.0002 |
| 244 |
HYPERVOLAEMIA |
1 |
0.0002 |
| 245 |
INFLAMMATORY MARKER INCREASED |
1 |
0.0002 |
| 246 |
ABDOMINAL TENDERNESS |
1 |
0.0002 |
| 247 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 248 |
DRUG TOLERANCE |
1 |
0.0002 |
| 249 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
0.0002 |
| 250 |
TOE AMPUTATION |
1 |
0.0002 |
| 251 |
FEELING HOT |
12 |
0.0002 |
| 252 |
PHARYNGEAL OEDEMA |
3 |
0.0002 |
| 253 |
INCREASED UPPER AIRWAY SECRETION |
1 |
0.0002 |
| 254 |
PERIORBITAL OEDEMA |
1 |
0.0002 |
| 255 |
SWOLLEN TONGUE |
6 |
0.0002 |
| 256 |
BLOOD LACTIC ACID INCREASED |
1 |
0.0002 |
| 257 |
POLYARTHRITIS |
1 |
0.0002 |
| 258 |
ANORECTAL DISCOMFORT |
1 |
0.0002 |
| 259 |
ABSCESS |
3 |
0.0002 |
| 260 |
MUSCLE TIGHTNESS |
3 |
0.0002 |
| 261 |
NORMAL NEWBORN |
1 |
0.0002 |
| 262 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
1 |
0.0002 |
| 263 |
WOUND INFECTION |
2 |
0.0002 |
| 264 |
JAW DISORDER |
1 |
0.0002 |
| 265 |
ANGIOEDEMA |
8 |
0.0002 |
| 266 |
RASH MACULO-PAPULAR |
4 |
0.0002 |
| 267 |
HYPERTENSIVE CRISIS |
2 |
0.0002 |
| 268 |
SKIN INFECTION |
2 |
0.0002 |
| 269 |
BLISTER |
10 |
0.0002 |
| 270 |
SKIN TOXICITY |
1 |
0.0002 |
| 271 |
MUSCULOSKELETAL DISCOMFORT |
3 |
0.0002 |
| 272 |
MOUTH SWELLING |
1 |
0.0002 |
| 273 |
METABOLIC DISORDER |
1 |
0.0002 |
| 274 |
VASCULITIS |
2 |
0.0002 |
| 275 |
SPINAL PAIN |
2 |
0.0002 |
| 276 |
COLD SWEAT |
3 |
0.0002 |
| 277 |
OFF LABEL USE |
148 |
0.0002 |
| 278 |
ATAXIA |
2 |
0.0002 |
| 279 |
LEUKOCYTOSIS |
3 |
0.0002 |
| 280 |
TENDON RUPTURE |
2 |
0.0002 |
| 281 |
INJECTION SITE DISCOLOURATION |
2 |
0.0002 |
| 282 |
TUBULOINTERSTITIAL NEPHRITIS |
3 |
0.0002 |
| 283 |
SWELLING OF EYELID |
1 |
0.0002 |
| 284 |
APPLICATION SITE VESICLES |
1 |
0.0002 |
| 285 |
HERPES SIMPLEX |
1 |
0.0002 |
| 286 |
DRUG SPECIFIC ANTIBODY PRESENT |
1 |
0.0002 |
| 287 |
PRURITUS |
59 |
0.0002 |
| 288 |
SKIN DISCOLOURATION |
7 |
0.0002 |
| 289 |
HYPOGAMMAGLOBULINAEMIA |
1 |
0.0002 |
| 290 |
GAIT INABILITY |
5 |
0.0001 |
| 291 |
POSTOPERATIVE WOUND INFECTION |
1 |
0.0001 |
| 292 |
ECCHYMOSIS |
1 |
0.0001 |
| 293 |
FORMICATION |
1 |
0.0001 |
| 294 |
OXYGEN SATURATION DECREASED |
8 |
0.0001 |
| 295 |
SKIN REACTION |
2 |
0.0001 |
| 296 |
PAPULE |
1 |
0.0001 |
| 297 |
PULMONARY TOXICITY |
1 |
0.0001 |
| 298 |
SEASONAL ALLERGY |
2 |
0.0001 |
| 299 |
FAECES SOFT |
1 |
0.0001 |
| 300 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0001 |
| 301 |
STEVENS-JOHNSON SYNDROME |
3 |
0.0001 |
| 302 |
EYE SWELLING |
5 |
0.0001 |
| 303 |
ACUTE KIDNEY INJURY |
20 |
0.0001 |
| 304 |
CHEST PAIN |
24 |
0.0001 |
| 305 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 306 |
FURUNCLE |
1 |
0.0001 |
| 307 |
SENSORY LOSS |
1 |
0.0001 |
| 308 |
HYPERHIDROSIS |
16 |
0.0001 |
| 309 |
LOCALISED INFECTION |
3 |
0.0001 |
| 310 |
LACTIC ACIDOSIS |
4 |
0.0001 |
| 311 |
EMBOLISM |
1 |
0.0001 |
| 312 |
MUSCLE SPASMS |
22 |
0.0001 |
| 313 |
SENSATION OF FOREIGN BODY |
1 |
0.0001 |
| 314 |
CARDIOVASCULAR DISORDER |
3 |
0.0001 |
| 315 |
HEPATITIS |
3 |
0.0001 |
| 316 |
PERIPHERAL SWELLING |
18 |
0.0001 |
| 317 |
HYSTERECTOMY |
1 |
0.0001 |
| 318 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 319 |
PURPURA |
1 |
0.0001 |
| 320 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 321 |
BONE DISORDER |
2 |
0.0001 |
| 322 |
RESPIRATORY ARREST |
3 |
0.0001 |
| 323 |
VOMITING |
51 |
0.0001 |
| 324 |
HEPATIC ENCEPHALOPATHY |
1 |
0.0001 |
| 325 |
SQUAMOUS CELL CARCINOMA |
1 |
0.0001 |
| 326 |
BLOOD SODIUM DECREASED |
2 |
0.0001 |
| 327 |
BLOOD URINE PRESENT |
2 |
0.0001 |
| 328 |
INTERNATIONAL NORMALISED RATIO INCREASED |
3 |
0.0001 |
| 329 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 330 |
WHITE BLOOD CELL COUNT INCREASED |
4 |
0.0001 |
| 331 |
TACHYCARDIA |
9 |
0.0001 |
| 332 |
PYREXIA |
35 |
0.0001 |
| 333 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 334 |
SINUS DISORDER |
2 |
0.0001 |
| 335 |
HYPOTONIA |
1 |
0.0001 |
| 336 |
LEUKOPENIA |
5 |
0.0001 |
| 337 |
VAGINAL DISCHARGE |
1 |
0.0001 |
| 338 |
HYPOTHERMIA |
1 |
0.0001 |
| 339 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 340 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 341 |
EAR DISCOMFORT |
1 |
0.0001 |
| 342 |
INJECTION SITE WARMTH |
2 |
0.0001 |
| 343 |
RHABDOMYOLYSIS |
4 |
0.0001 |
| 344 |
PETECHIAE |
1 |
0.0001 |
| 345 |
TRANSFUSION |
1 |
0.0001 |
| 346 |
DYSPNOEA |
54 |
0.0001 |
| 347 |
SCRATCH |
1 |
0.0001 |
| 348 |
SUDDEN DEATH |
1 |
0.0001 |
| 349 |
RENAL PAIN |
1 |
0.0001 |
| 350 |
RETCHING |
2 |
0.0001 |
| 351 |
LOSS OF CONSCIOUSNESS |
12 |
0.0001 |
| 352 |
RASH PRURITIC |
5 |
0.0001 |
| 353 |
SWELLING FACE |
6 |
0.0001 |
| 354 |
CLOSTRIDIUM DIFFICILE INFECTION |
2 |
0.0001 |
| 355 |
ASPIRATION |
1 |
0.0001 |
| 356 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
1 |
0.0001 |
| 357 |
BLOOD PRESSURE DECREASED |
6 |
0.0001 |
| 358 |
TRANSAMINASES INCREASED |
2 |
0.0001 |
| 359 |
NERVE INJURY |
1 |
0.0001 |
| 360 |
SEPSIS |
10 |
0.0001 |
| 361 |
THROMBOCYTOPENIA |
10 |
0.0001 |
| 362 |
NEPHROPATHY TOXIC |
1 |
0.0001 |
| 363 |
FISTULA |
1 |
0.0001 |
| 364 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 365 |
GASTRIC HAEMORRHAGE |
1 |
0.0001 |
| 366 |
EYELID OEDEMA |
1 |
0.0001 |
| 367 |
HYPOXIA |
3 |
0.0001 |
| 368 |
PRODUCT PRESCRIBING ERROR |
2 |
0.0001 |
| 369 |
MACULAR DEGENERATION |
1 |
0.0001 |
| 370 |
RASH ERYTHEMATOUS |
4 |
0.0001 |
| 371 |
SKIN EXFOLIATION |
7 |
0.0001 |
| 372 |
SCHIZOPHRENIA |
1 |
0.0001 |
| 373 |
PRESYNCOPE |
2 |
0.0001 |
| 374 |
DISCOMFORT |
5 |
0.0001 |
| 375 |
INTERCEPTED PRODUCT PREPARATION ERROR |
1 |
0.0001 |
| 376 |
SPINAL OPERATION |
1 |
0.0001 |
| 377 |
HYPERCALCAEMIA |
1 |
0.0001 |
| 378 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 379 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
16 |
0.0001 |
| 380 |
TREMOR |
13 |
0.0001 |
| 381 |
THERAPY CESSATION |
4 |
0.0001 |
| 382 |
SEIZURE |
9 |
0.0001 |
| 383 |
INFLAMMATION |
4 |
0.0001 |
| 384 |
UNRESPONSIVE TO STIMULI |
2 |
0.0001 |
| 385 |
SKIN ULCER |
2 |
0.0001 |
| 386 |
RASH GENERALISED |
2 |
0.0001 |
| 387 |
DEEP VEIN THROMBOSIS |
5 |
0.0001 |
| 388 |
BLOOD CREATININE INCREASED |
5 |
0.0001 |
| 389 |
ADVERSE REACTION |
1 |
0.0001 |
| 390 |
EYE HAEMORRHAGE |
1 |
0.0001 |
| 391 |
JOINT RANGE OF MOTION DECREASED |
1 |
0.0001 |
| 392 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 393 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 394 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
4 |
0.0001 |
| 395 |
RESPIRATORY DISTRESS |
2 |
0.0001 |
| 396 |
NAUSEA |
57 |
0.0001 |
| 397 |
HYPOMAGNESAEMIA |
1 |
0.0001 |
| 398 |
HAEMOPTYSIS |
2 |
0.0001 |
| 399 |
APHONIA |
1 |
0.0001 |
| 400 |
MASS |
1 |
0.0001 |
| 401 |
INCORRECT DRUG ADMINISTRATION DURATION |
2 |
0.0001 |
| 402 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 403 |
HYPOKINESIA |
1 |
0.0001 |
| 404 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 405 |
FLUID OVERLOAD |
1 |
0.0001 |
| 406 |
DYSPHONIA |
4 |
0.0001 |
| 407 |
BONE PAIN |
4 |
0.0001 |
| 408 |
LABORATORY TEST ABNORMAL |
2 |
0.0001 |
| 409 |
URINARY INCONTINENCE |
2 |
0.0001 |
| 410 |
ADVERSE DRUG REACTION |
6 |
0.0001 |
| 411 |
TOXIC EPIDERMAL NECROLYSIS |
1 |
0.0001 |
| 412 |
INSURANCE ISSUE |
1 |
0.0001 |
| 413 |
HIP ARTHROPLASTY |
1 |
0.0001 |
| 414 |
SWELLING |
6 |
0.0001 |
| 415 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 416 |
PNEUMOTHORAX |
1 |
0.0001 |
| 417 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 418 |
HALLUCINATION, AUDITORY |
1 |
0.0001 |
| 419 |
PREMATURE DELIVERY |
1 |
0.0001 |
| 420 |
THROMBOSIS |
5 |
0.0001 |
| 421 |
VENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 422 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 423 |
FUNGAL INFECTION |
2 |
0.0001 |
| 424 |
SKIN DISORDER |
2 |
0.0001 |
| 425 |
HYPOTENSION |
12 |
0.0001 |
| 426 |
FACE OEDEMA |
1 |
0.0001 |
| 427 |
CANDIDA INFECTION |
1 |
0.0001 |
| 428 |
NEUTROPENIA |
8 |
0.0001 |
| 429 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 430 |
AMENORRHOEA |
1 |
0.0001 |
| 431 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 432 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 433 |
INFECTION |
8 |
0.0001 |
| 434 |
PELVIC PAIN |
1 |
0.0001 |
| 435 |
PAIN IN EXTREMITY |
16 |
0.0001 |
| 436 |
INJECTION SITE MASS |
2 |
0.0001 |
| 437 |
AGRANULOCYTOSIS |
1 |
0.0001 |
| 438 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 439 |
NECK PAIN |
3 |
0.0001 |
| 440 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 441 |
FOOT FRACTURE |
1 |
0.0001 |
| 442 |
RENAL FAILURE |
7 |
0.0001 |
| 443 |
PROTEINURIA |
1 |
0.0001 |
| 444 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 445 |
FEELING JITTERY |
1 |
0.0001 |
| 446 |
CHOLESTASIS |
1 |
0.0001 |
| 447 |
CONTUSION |
5 |
0.0001 |
| 448 |
ATRIAL FIBRILLATION |
5 |
0.0001 |
| 449 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 450 |
CHOKING |
1 |
0.0001 |
| 451 |
PREGNANCY |
1 |
0.0000 |
| 452 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 453 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 454 |
TREATMENT FAILURE |
4 |
0.0000 |
| 455 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 456 |
DIARRHOEA |
30 |
0.0000 |
| 457 |
HYPOACUSIS |
2 |
0.0000 |
| 458 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 459 |
BLOOD PRESSURE INCREASED |
7 |
0.0000 |
| 460 |
APPLICATION SITE PAIN |
1 |
0.0000 |
| 461 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 462 |
RASH PAPULAR |
1 |
0.0000 |
| 463 |
PRODUCT USE IN UNAPPROVED INDICATION |
11 |
0.0000 |
| 464 |
APPLICATION SITE PRURITUS |
1 |
0.0000 |
| 465 |
DRUG INEFFECTIVE |
58 |
0.0000 |
| 466 |
MUSCULAR WEAKNESS |
5 |
0.0000 |
| 467 |
TINNITUS |
2 |
0.0000 |
| 468 |
SHOCK |
1 |
0.0000 |
| 469 |
ADVERSE EVENT |
4 |
0.0000 |
| 470 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 471 |
BURNING SENSATION |
3 |
0.0000 |
| 472 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
3 |
0.0000 |
| 473 |
OEDEMA PERIPHERAL |
5 |
0.0000 |
| 474 |
LIVER INJURY |
1 |
0.0000 |
| 475 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 476 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 477 |
SYNCOPE |
4 |
0.0000 |
| 478 |
UNEVALUABLE EVENT |
3 |
0.0000 |
| 479 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 480 |
INCORRECT DOSE ADMINISTERED |
9 |
0.0000 |
| 481 |
DIPLOPIA |
1 |
0.0000 |
| 482 |
DEAFNESS |
1 |
0.0000 |
| 483 |
SEDATION |
1 |
0.0000 |
| 484 |
MUSCULOSKELETAL PAIN |
2 |
0.0000 |
| 485 |
APPLICATION SITE ERYTHEMA |
1 |
0.0000 |
| 486 |
EAR INFECTION |
1 |
0.0000 |
| 487 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 488 |
OEDEMA |
2 |
0.0000 |
| 489 |
LIMB INJURY |
1 |
0.0000 |
| 490 |
SKIN LESION |
1 |
0.0000 |
| 491 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 492 |
PANCYTOPENIA |
2 |
0.0000 |
| 493 |
WOUND |
1 |
0.0000 |
| 494 |
ABDOMINAL DISCOMFORT |
6 |
0.0000 |
| 495 |
RENAL IMPAIRMENT |
3 |
0.0000 |
| 496 |
HYPONATRAEMIA |
2 |
0.0000 |
| 497 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 498 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0000 |
| 499 |
FLATULENCE |
2 |
0.0000 |
| 500 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 501 |
HYPERSOMNIA |
1 |
0.0000 |
| 502 |
DECREASED APPETITE |
8 |
0.0000 |
| 503 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 504 |
NEEDLE ISSUE |
1 |
0.0000 |
| 505 |
DYSSTASIA |
1 |
0.0000 |
| 506 |
MALAISE |
15 |
0.0000 |
| 507 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 508 |
DIZZINESS |
17 |
0.0000 |
| 509 |
ABDOMINAL PAIN UPPER |
7 |
0.0000 |
| 510 |
MATERNAL EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 511 |
HYPERTENSION |
7 |
0.0000 |
| 512 |
INJECTION SITE RASH |
1 |
0.0000 |
| 513 |
DRUG ADMINISTRATION ERROR |
1 |
0.0000 |
| 514 |
HOSPITALISATION |
5 |
0.0000 |
| 515 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 516 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 517 |
PARAESTHESIA |
5 |
0.0000 |
| 518 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 519 |
CHOLELITHIASIS |
1 |
0.0000 |
| 520 |
IMPAIRED HEALING |
1 |
0.0000 |
| 521 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 522 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 523 |
EYE PRURITUS |
1 |
0.0000 |
| 524 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 525 |
PRODUCT QUALITY ISSUE |
4 |
0.0000 |
| 526 |
MYALGIA |
5 |
0.0000 |
| 527 |
FEELING ABNORMAL |
7 |
0.0000 |
| 528 |
HAEMATURIA |
1 |
0.0000 |
| 529 |
ILLNESS |
3 |
0.0000 |
| 530 |
HAEMORRHAGE |
3 |
0.0000 |
| 531 |
PLATELET COUNT DECREASED |
3 |
0.0000 |
| 532 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 533 |
PAIN |
17 |
0.0000 |
| 534 |
CRYING |
1 |
0.0000 |
| 535 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 536 |
PANIC ATTACK |
1 |
0.0000 |
| 537 |
RESTLESSNESS |
1 |
0.0000 |
| 538 |
EPISTAXIS |
2 |
0.0000 |
| 539 |
HYPOAESTHESIA |
4 |
0.0000 |
| 540 |
ASTHENIA |
10 |
0.0000 |
| 541 |
HALLUCINATION |
2 |
0.0000 |
| 542 |
COLITIS |
1 |
0.0000 |
| 543 |
CONDITION AGGRAVATED |
8 |
0.0000 |
| 544 |
DIABETES MELLITUS |
2 |
0.0000 |
| 545 |
GAIT DISTURBANCE |
5 |
0.0000 |
| 546 |
INJECTION SITE SWELLING |
2 |
0.0000 |
| 547 |
INJECTION SITE PAIN |
8 |
0.0000 |
| 548 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 549 |
DISORIENTATION |
1 |
0.0000 |
| 550 |
WEIGHT DECREASED |
7 |
0.0000 |
| 551 |
DEVICE BREAKAGE |
1 |
0.0000 |
| 552 |
CARDIAC ARREST |
2 |
0.0000 |
| 553 |
INJECTION SITE ERYTHEMA |
3 |
0.0000 |
| 554 |
POLLAKIURIA |
1 |
0.0000 |
| 555 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 556 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 557 |
MENTAL DISORDER |
1 |
0.0000 |
| 558 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 559 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 560 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 561 |
SUICIDAL IDEATION |
2 |
0.0000 |
| 562 |
SKIN IRRITATION |
1 |
0.0000 |
| 563 |
ARTHRALGIA |
9 |
0.0000 |
| 564 |
RENAL DISORDER |
1 |
0.0000 |
| 565 |
BLOOD GLUCOSE INCREASED |
4 |
0.0000 |
| 566 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 567 |
MIGRAINE |
2 |
0.0000 |
| 568 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 569 |
HEADACHE |
13 |
0.0000 |
| 570 |
DRUG INTOLERANCE |
2 |
0.0000 |
| 571 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 572 |
ALOPECIA |
4 |
0.0000 |
| 573 |
HEART RATE INCREASED |
2 |
0.0000 |
| 574 |
AGGRESSION |
1 |
0.0000 |
| 575 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 576 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 577 |
NERVOUSNESS |
1 |
0.0000 |
| 578 |
SPEECH DISORDER |
1 |
0.0000 |
| 579 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 580 |
EYE PAIN |
1 |
0.0000 |
| 581 |
ANXIETY |
5 |
0.0000 |
| 582 |
DEATH |
15 |
0.0000 |
| 583 |
LETHARGY |
1 |
0.0000 |
| 584 |
ABDOMINAL PAIN |
4 |
0.0000 |
| 585 |
COVID-19 |
3 |
0.0000 |
| 586 |
SURGERY |
1 |
0.0000 |
| 587 |
WHEEZING |
1 |
0.0000 |
| 588 |
IRRITABILITY |
1 |
0.0000 |
| 589 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 590 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 591 |
STOMATITIS |
1 |
0.0000 |
| 592 |
VERTIGO |
1 |
0.0000 |
| 593 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 594 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 595 |
PRODUCT USE ISSUE |
3 |
0.0000 |
| 596 |
ANAEMIA |
3 |
0.0000 |
| 597 |
PNEUMONIA |
5 |
0.0000 |
| 598 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 599 |
DEHYDRATION |
2 |
0.0000 |
| 600 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 601 |
VISION BLURRED |
2 |
0.0000 |
| 602 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 603 |
MOBILITY DECREASED |
1 |
0.0000 |
| 604 |
UNDERDOSE |
1 |
0.0000 |
| 605 |
PRODUCT DOSE OMISSION ISSUE |
4 |
0.0000 |
| 606 |
HOT FLUSH |
1 |
0.0000 |
| 607 |
DRUG INTERACTION |
2 |
0.0000 |
| 608 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 609 |
CARDIAC FAILURE |
1 |
0.0000 |
| 610 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 611 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 612 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 613 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 614 |
DEVICE ISSUE |
1 |
0.0000 |
| 615 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
2 |
0.0000 |
| 616 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 617 |
BREAST CANCER |
1 |
0.0000 |
| 618 |
COUGH |
3 |
0.0000 |
| 619 |
DYSPHAGIA |
1 |
0.0000 |
| 620 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 621 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 622 |
CONSTIPATION |
2 |
0.0000 |
| 623 |
FALL |
3 |
0.0000 |
| 624 |
INFLUENZA |
1 |
0.0000 |
| 625 |
ASTHMA |
1 |
0.0000 |
| 626 |
PALPITATIONS |
1 |
0.0000 |
| 627 |
JOINT SWELLING |
1 |
0.0000 |
| 628 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 629 |
FATIGUE |
6 |
0.0000 |
| 630 |
INSOMNIA |
2 |
0.0000 |
| 631 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 632 |
DRUG DEPENDENCE |
1 |
0.0000 |
| 633 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 634 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 635 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 636 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 637 |
OVERDOSE |
1 |
0.0000 |